Asco 2025 · Posters · Cáncer Genitourinario · Cristina Suárez Sr, MD, PhD Volver

Efficacy and safety of second-line cabozantinib ± atezolizumab for patients with advanced renal cell carcinoma after progression on immuno-oncology combinations: Subgroup analysis of CONTACT-03.

Abstract: 4523
Poster Bd #: 323
Descargar Poster

Cristina Suárez Sr, MD, PhD

Medical Oncology, Vall d´Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d´Hebron, Vall d´Hebron Barcelona Hospital Campus

Una iniciativa científica de: Eco Logo
Clover sgm Logo
Con el patrocinio de: Regeneron Logo